Table 1.

Design and baseline characteristics of fenestrated endovascular aneurysm repair studies

Reference	Study design	Country	Sites	n	Follow‐up (months)	Definition of early mortality	Definition of renal insufficiency	Aneurysm morphology
Oikonomou et al. 19	Retrospective cohort	Germany	1	141	33	30 days	Reduction eGFR > 30%	Short‐necked, juxtarenal and suprarenal
Roy et al. 11	Case series	UK	1	173	34	In‐hospital	> 50% rise in creatinine	n.s.
Wooster et al. 16	Retrospective cohort	USA	1	39	6·7	In‐hospital	n.s.	Extension to < 4 mm of renal artery and not above highest renal
Blankensteijn et al. 12	Case series	Netherlands	13	60	16·4	30 days	n.s.	Neck length < 15 mm and not extending above renal arteries
Katsargyris et al. 20	Retrospective cohort	Germany	1	384	20	30 days	> 30% rise in creatinine	Short‐necked, juxtarenal and suprarenal
Caradu et al. 7	Retrospective cohort	France	1	90	19	30 days or in‐hospital	‘Acute kidney injury’ (definition n.s.)	n.s.
Saratzis et al. 22	Case–control	UK	1	58	20	n.s.	> 50% rise in creatinine	Short‐necked and juxtarenal (suprarenal excluded)
Vemuri et al. 13	Case series	USA	7	57	1·75	30 days	n.s.	n.s.
Kristmundsson et al. 14	Case series	Sweden	1	54	67	30 days	> 30% decrease in eGFR	Short‐necked and juxtarenal (suprarenal excluded)
Grimme et al. 15	Case series	Netherlands	1	138	13	30 days	> 30% decrease in eGFR	Short‐necked, juxtarenal and suprarenal
Banno et al. 17	Retrospective cohort	France	1	80	14	30 days	> 50% rise in creatinine	Short‐necked and juxtarenal (suprarenal excluded)
Oderich et al. 23	Prospective non‐randomized	USA	14	67	37	30 days	> 30% decrease in eGFR in two tests	Neck length ≥ 4 mm and ≤ 15 mm
Perot et al. 18	Retrospective cohort	France	1	115	20	30 days	Creatinine clearance < 60 ml/min	Suprarenal and juxtarenal
Manning et al. 21	Retrospective cohort	UK	1	20	1	n.s.	n.s.	n.s.

eGFR, Estimated glomerular filtration rate; n.s., not stated.